Status:
NOT_YET_RECRUITING
Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Collaborating Sponsors:
Shanxi Bethune Hospital
Henan Fantasy Intelligent Technology Co., Ltd
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
This study aims to evaluate the clinical efficacy of breath-guided improvement of COPD exercise ability, establish a breath-guided rehabilitation program of intelligent iot and remote home, improve CO...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is the most common chronic airway disease in China. Based on the digital management platform, 548 patients with COPD in stable stage were selected as the r...
Eligibility Criteria
Inclusion
- Patients with COPD in stable stage
- Patients with grade 2 to 4 lung function
- Age 40\~80 years old
- Be able to use smart phones, computers and other devices independently or with the help of family members during home training
- Volunteer for treatment and sign an informed consent form
Exclusion
- Pregnant or lactating women and patients with recent pregnancy plans
- Delirious, dementia, all kinds of mental illness
- Tumor patients who have undergone resection, radiation, and chemotherapy within 5 years
- Patients with severe osteoarthropathy or osteoporosis, unstable fractures
- Patients with severe visual impairment that cannot be improved or who have epilepsy or vertigo and cannot use VR devices
- Patients with progressive neuromuscular disease
- Patients with pulmonary abscess, pulmonary interstitial fibrosis, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism and other pulmonary diseases
- Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, grade 3 or above cardiac function, stroke, cerebral hemorrhage, etc.)
- Patients with severe liver disease (cirrhosis, portal hypertension and bleeding caused by esophageal and gastric varices, etc.) and severe kidney disease (dialysis, kidney transplantation, etc.)
- Participants who were participating in other clinical trials within 1 month prior to enrollment
- People who stay in bed for a long time for various reasons
Key Trial Info
Start Date :
June 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
548 Patients enrolled
Trial Details
Trial ID
NCT06963333
Start Date
June 15 2025
End Date
July 31 2028
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Zhengzhou, Henan, China, 450000